Editor's Note: This slideshow, originally published in July 2018, was updated July 23, 2019, to reflect companies from the original list that have been (or are being) acquired, as well as two newcomers to the list.

Needham & Co.'s Mike Matson has a list of 25 public medtech companies he thinks are likely to standout to larger companies looking for M&A targets. Matson recently updated his list to include two newcomers, taking the place of two companies from last year's list that have since been acquired.

Read on to see the most current list (in alphabetical order), with additional insights and updates from the most recent MD+DI coverage of each.